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Abstract
Pseudomonas aeruginosa is a key opportunistic pathogen characterized by its biofilm formation ability and high-level
multiple antibiotic resistance. By screening a library of random transposon insertion mutants with an increased biofilmspecifc antibiotic susceptibility, we previously identified 3 genes or operons of P. aeruginosa UCBPP-PA14 (ndvB,
PA1875–1877 and tssC1) that do not affect biofilm formation but are involved in biofilm-specific antibiotic resistance. In
this study, we demonstrate that PA0756–0757 (encoding a putative two-component regulatory system), PA2070 and
PA5033 (encoding hypothetical proteins of unknown function) display increased expression in biofilm cells and also
have a role in biofilm-specific antibiotic resistance. Furthermore, deletion of each of PA0756, PA2070 and PA5033
resulted in a significant reduction of lethality in Caenorhabditis elegans, indicating a role for these genes in both biofilmspecific antibiotic resistance and persistence in vivo. Together, these data suggest that these genes are potential targets
for antimicrobial agents.
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significant decrease in biofilm-specific resistance relative to the
wild type strain [10–12]. Furthermore, these mutants have no
defect in planktonic antibiotic resistance. ndvB encodes a
glucosyltransferase that is important for the synthesis of cyclic-b
1, 3 glucans [14]. We determined that P. aeruginosa cyclic glucans
contribute to antibiotic resistance in biofilms by interacting with
antibiotics and sequestering them away from their cellular targets
[10]. ndvB is also important for expression of ethanol oxidation
genes, suggesting multiple roles of NdvB [13]. PA1875–1877 is
part of an operon that encodes an efflux pump that removes
antibiotics from the cells within the biofilm [11]. tssC1 is a
component of a P. aeruginosa type VI secretion system that is
involved in biofilm-specific antibiotic resistance through an
unknown mechanism [12].
The three initially characterized biofilm-specific antibiotic
resistance loci are not linked by cellular function, suggesting that
there are multiple pathways leading to resistance in biofilms. To
further support this hypothesis, the three novel genetic loci that
are the subject of the current publication, PA0756–0757,
PA2070 and PA5033, are not predicted to belong to similar
pathways/functions. PA0756 and PA0757 are predicted to
encode a two-component regulatory system. PA2070 and
PA5033 are both predicted to encode hypothetical proteins of
unknown function.
In this study, we investigate the roles of PA0756–0757, PA2070
and PA5033 in biofilm-specific antibiotic resistance. We also
explore the impact of the inactivation of these genes in an in vivo
pathogenesis model involving the nematode Caenorhabditis elegans.

Introduction
Pseudomonas aeruginosa is a well-established opportunistic pathogen capable of infecting animals and plants as demonstrated with
strain UCBPP-PA14 (PA14) [1]. Gene expression differs in biofilm
and planktonic cells and indeed, about 1% of P. aeruginosa genes
including those related to antibiotic resistance and virulence
factors show differential expression in the two growth modes [2].
Antibiotic resistance in biofilms is due to a combination of
different factors that act together to result in a level of resistance
that is greater than that of planktonic cultures [3–6]. These factors
include slow penetration of antibiotic through the biofilm [7],
persister formation [8] and the induction of a lipid modification
operon by extracellular matrix DNA [9]. Over the past several
years, we have described other novel antibiotic resistance
mechanisms (e.g., glucan-mediated sequestration and the expression of a biofilm-specific efflux pump) that are only expressed in a
biofilm [10–12].
In order to identify novel mechanisms responsible for biofilmspecific antibiotic resistance, we developed a high-throughput
system to identify mutants of P. aeruginosa that do not develop the
characteristic increase in resistance to antibiotics when grown in a
biofilm [10]. Several mutants were identified in this screen. We
have previously published descriptions of the analysis of 3 of these
mutants involving, respectively, ndvB, PA1875–1877 and tssC1
genes [10–13]. Analysis of deletion mutants of these genes revealed
that these mutants share a common phenotype: they form biofilms
and grow as well as the wild type strain, yet they display a
PLOS ONE | www.plosone.org
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formation, biofilms were formed in 96-well microtitre plates for
32 h at 37uC, stained with 0.1% crystal violet, followed by the
solubilization of the biofilm-associated crystal violet in 95%
ethanol and the measurement of their optical densities at
550 nm [18]. The data obtained from two separate experiments
(each with quadruplicate samples) were assessed by one-way
analysis of variance (ANOVA).

Materials and Methods
Bacterial strains, media, and reagents
All P. aeruginosa strains used in this study were derivatives of the
PA14 wild-type strain and are listed in Table 1. The DndvB, DtssC1
and DPA1874-1877 mutants have previously been reported
elsewhere [10–12]. Additional mutants with unmarked deletion
of PA0756–0757 (i.e., PA14_54510-54500), PA2070 (PA14_
37730) or PA5033 (PA14_66540) gene were constructed in
PA14 by allelic exchange with pEX18Gm derivatives as previously
described [10,15]. Genes were cloned into the pJB866 vector as
previously described [11], with open reading frames inserted
downstream from the Pm promoter, which is capable of induction
by m-toluic acid [16]. Primers used for the construction of deletion
mutants and pJB866 derivatives are listed in Table 2. Bacterial
cells were grown at 37uC in rich medium (Luria-Bertani [LB]
broth) or minimal medium. The minimal medium (M63-arginine)
contained M63 salts (1% potassium phosphate [monobasic] and
0.2% ammonium sulfate) supplemented with arginine (0.4%) and
MgSO4 (1 mM) [17]. Tobramycin, gentamicin, and ciprofloxacin
were purchased from Research Production International (Mt.
Prospect, Illinois, USA), Sigma-Aldrich Canada Ltd (Oakville,
Ontario, Canada) and MP Biomedicals (Solon, Ohio, USA),
respectively.

Quantitative real-time PCR (qPCR) analysis
RNA was extracted from planktonic cultures or colony biofilms
grown at 37uC. Planktonic cultures were grown in M63-arginine
medium to exponential phase. Colony biofilms on M63-arginine
agar plates were prepared by distributing single drops of a
saturated overnight culture of each strain on the surface of the
agar plate (one strain per plate). The plates were incubated for
24 h at 37uC followed by 16 h at room temperature [11]. Colonies
were scraped from the surface of the plates and RNA extraction
and cDNA synthesis were performed as previously described [11].
cDNA was quantified using SYBR-green detection of PCR
products with the MyiQ single-color detection system (Bio-Rad).
Each 20 ml qPCR reaction contained 2 ml cDNA (,1.2 mg), 10 ml
SYBR Green PCR Master Mix (Applied BioSystems), and
100 pmol of each primer. The following thermal cycler conditions
were used: 90 s at 95uC, followed by 45 cycles (with one cycle
consisting of 60 s at 95uC, 30 s at 56uC, and 30 s at 72uC). qPCR
primers are listed in Table 2. RNA isolated from at least two
independent cell cultures were each tested in triplicate qPCR
reactions, with expression of rpoD used as a reference standard.
Statistical significance was determined by Student’s t-tests.

Biofilm formation assays
These were conducted by using both the air liquid interface
assay and the 96-well microtitre plate assay as described previously
using M63-arginine medium [18]. Briefly, in the air liquid
interface assay, appropriately diluted overnight cultures were
added into the wells of the angled (30u) 6-well plates, followed by
the incubation at 37uC for 24 h. After removing the culture from
the wells and gently washing, the medium was added to cover the
bottom of the wells and the biofilms were analyzed on an inverted
microscope by phase-contrast microscopy. To quantify biofilm

Antibiotic resistance assays
Minimum bactericidal concentrations were determined for
biofilm (MBC-B) and planktonic (MBC-P) cultures as previously
described [10,11]. Briefly, overnight cultures of bacteria were

Table 1. P. aeruginosa strains and plasmids used in this study.

Strain or plasmid

Description

Source

Strain
PA14

P. aeruginosa burn wound isolate

[1]

TFM15

PA14 DndvB

[10]

TFM49

PA14 DPA2070

This study

TFM50

PA14 DtssC1

[12]

TFM57

PA14 DPA5033

This study

TMF65

PA14 DPA1874-1877

[11]

TFM73

PA14 DPA0756-0757

This study

TFM158

PA14 DndvB DPA0756-0757

This study

pEX18Gm

Broad-host-range gene replacement vector, sacB,
gentamicin resistance

[15]

pJB866

Expression vector containing the m-toluic acid inducible
promoter Pm; tetracycline resistance

[16]

pJB866-PA0756-0757

pJB866 with the PA0756-0757genes inserted downstream
from the Pm promoter

This study

pJB866-PA2070

pJB866 with the PA2070 gene inserted downstream
from the Pm promoter

This study

pJB866-PA5033

pJB866 with the PA5033gene inserted downstream
from the Pm promoter

This study

Plasmid

doi:10.1371/journal.pone.0061625.t001
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Table 2. Primers used in this study.

Primer

Sequence (59 to 39)*

Function
Deletion of PA0756-0757

PA0756 F1

CACTGAATTCTGCCAAGGCTGTAGGTGAAC

PA0756 R1

GTTCTCTAGACGAGCTGCGGATGATCTTCCA

Deletion of PA0756-0757

PA0757 F2

GTTGTCTAGATTCCCGCCGCCGACCGCGAGC

Deletion of PA0756-0757

PA0757 R2

TGAGCAAGCTTGCCGACAAAGTCCAACAGG

Deletion of PA0756-0757

PA2070 F1

ACTGGAGCTCATGGCGCTCGTCGTGCTTCT

Deletion of PA2070

PA2070 R1

GTTATCTAGAGCCGGTCACCTCGATTCGTT

Deletion of PA2070

PA2070 F2

GTTGTCTAGATTCAGCAACCAGACCTACAC

Deletion of PA2070

PA2070 R2

AGTCAAGCTTACCAGCAGGTCTTCGGAGTG

Deletion of PA2070

PA5033 F1

AGCAGAATTCACCATCACCGCTGCCTATCC

Deletion of PA5033

PA5033 R1

TTAATCTAGAACCACGTTGCCGAAGCTGT

Deletion of PA5033

PA5033 F2

TTAATCTAGAATACAGCATCGGCGCCAGC

Deletion of PA5033

PA5033 R2

GTGTAAGCTTCCGCAAGGTGGTCTCGTC

Deletion of PA5033

PA0756 JB-F

GTTGGAGCTCATGCGCATCCTTCTGGTGGAA

Cloning PA0756-0757into pJB866

PA0757 JB-R

GTTGAAGCTTGGAAGCCGCCACCAGCATGCTG

Cloning PA0756-0757into pJB866

PA2070 F7

CAACGAGCTCATGCACCGATCGCTCCAC

Cloning PA2070 into pJB866

PA2070 R7

GTTGAAGCTTGCGCCGGCATCAGAAGCTGT

Cloning PA2070 into pJB866

PA5033 F7

CAACGAGCTCATGAAACCAGCGATCAAGCG

Cloning PA5033into pJB866
Cloning PA5033into pJB866

PA5033 R7

GTTCAAGCTTCCTCCGGCGCGTTGGTTGGC

rpoD F3

CATCCGCATGATCAACGACA

qPCR

rpoD R2

GATCGATATAGCCGCTGAGG

qPCR

PA0756 F4

TCGGTGGCGAACAGTTGCAG

qPCR

PA0756 R4

GGCCAGTTGCTCCTTGCTCA

qPCR

PA2070 F4

CTCCGCGGTGGATCTCAACA

qPCR

PA2070 R4

GTCGAAGCGGCCTTCGTTCA

qPCR

PA5033 F4

GGCGTTCTGGTAGGAACCTG

qPCR

PA5033 R4

AGACCACGTTGCCGAAGCTG

qPCR

*Locations of restriction sites are underlined and in bold.
doi:10.1371/journal.pone.0061625.t002

was conducted as described [20]. Briefly, P. aeruginosa strains were
seeded onto slow killing low osmolarity plates. These plates were
incubated at 37uC for 24 hours and then room temperature for
24 hours. Thirty synchronized L4 or young adult worms were
placed onto the slow killing plates and the plates were incubated at
25uC for a total of 72 hours. Viability of the worms was assessed
every 24 hours by gently stroking them. Worms that did not move
were scored as dead and were removed from the plate. Escherichia
coli OP50 is a standard food source of C. elegans and served as a
control in this experiment.

diluted (1:50) in M63-arginine in 96-well microtitre plates. For
MBC-B assays, biofilms were formed over 24 h, planktonic cells
were removed, and the biofilms were exposed to serial dilutions of
antibiotics (ranged from 6.25 to 400 mg/ml for tobramycin, 12.5 to
800 mg/ml for gentamicin, and 2.5 to 160 mg/ml for ciprofloxacin). For MBC-P assays, antibiotics were added at the same time
the plates were inoculated with the following concentrations used:
1 to 64 mg/ml for tobramycin, 2 to 128 mg/ml for gentamicin, and
0.5 to 32 mg/ml for ciprofloxacin. After 24 h of antibiotic
treatment, bacterial survival was determined by spotting a small
amount (ca. 3 ml) of culture on LB agar plates immediately after
antibiotic treatment (MBC-P) or following a 24 h recovery period
in which surviving cells can detach from biofilms into antibioticfree growth media (MBC-B).
For another measure of planktonic antibiotic resistance,
minimum inhibitory concentrations (MICs) were determined in
LB broth using the two-fold broth dilution method [19]. For
strains carrying pJB866 derivatives (Table 1), MICs were
determined in LB or M63-arginine containing 2 mM m-toluic
acid to induce expression of cloned genes. The concentrations of
antibiotics ranged from 0.0625 to 64 mg/ml.

Results
Characterization of three novel biofilm-specific antibiotic
resistance genes
A genetic screen was previously conducted in order to identify
novel genes involved in biofilm-specific resistance to the antibiotic
tobramycin in P. aeruginosa PA14 [10]. Several candidate
transposon-insertion mutants with increased biofilm-specific susceptibility to tobramycin were isolated from the initial screen.
After conducting secondary screening (growth and biofilm
formation; data not shown), six mutants that could form biofilms
and grow as well as the wild-type strain, were selected for further
study. The transposon element carried by each of the mutant
strains was cloned and the DNA sequence flanking the transposon

C. elegans slow-killing assay
The C. elegans N2 Bristol wild-type strain was maintained using
nematode growth medium and the P. aeruginosa slow-killing assay
PLOS ONE | www.plosone.org
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was determined and compared to the completed genome of P.
aeruginosa [21]. We have completed the initial characterization of
three genes/operon, ndvB, PA1875-1877 and tssC1 [10–13]. In
the current study, we focus on PA0756-0757 (an operon
encoding regulator and sensor histidine kinase of a putative
two-component regulatory system), PA2070 (encoding a hypothetical membrane protein), and PA5033 (encoding a hypothetical protein).
In order to assess the importance of PA0756-0757, PA2070
and PA5033 in biofilm-specific antibiotic resistance, we generated in-frame deletions of PA2070 and PA5033 as well as the
entire PA0756-0757 locus. The resulting deletion mutants,
DPA0765-0757, DPA2070 and DPA5033, were assessed for
their growth, biofilm formation and antibiotic resistance
phenotype. All of these mutants exhibited a wild-type level of
growth in both LB and M63 medium (data not shown). They
were also competent in biofilm formation as shown by
representative images of biofilms that were formed in 6-well
microtitre dishes in the air liquid interface assay (Figure 1A) as
well as by the quantification of the biofilm formation from the
microtitre plate assay (Figure 1B). The antibiotic resistance
phenotype obtained for these mutants by performing MBC-P
and MBC-B assays are shown in Table 3. The previously
characterized DndvB mutant was included as control [10]. Three
typical anti-pseudomonal antibiotics, tobramycin, gentamicin
and ciprofloxacin, were tested. The MBC-P and MBC-B assays
are static assays performed in sterile 96-well microtitre plates.
The MBC-P assay is a measure of planktonic resistance that can
be directly compared to MBC-B values that are indicative of
resistance within a biofilm [10]. All three deletion mutants
displayed reduced biofilm-specific resistance to tobramycin and
gentamicin while showing no defect in resistance to ciprofloxacin. In the MBC-P assay, the DPA5033 mutant was more
sensitive to tobramycin and gentamicin, the DPA0765-0757
mutant was also more sensitive to tobramycin, while the
sensitivity of the DPA2070 mutant to three antibiotics tested
was unaffected (Table 3).
Since the DPA0756-0757 and DPA5033 deletion mutants
displayed increased sensitivity to tobramycin or gentamicin in
the MBC-P assays, we further assessed planktonic antibiotic
resistance of the deletion mutants using the standard minimal
inhibitory concentration (MIC) assay. DPA0756-0757, DPA2070
and DPA5033 exhibited no defects in this assay (Table 4), when
tested against tobramycin and gentamicin. However, the
DPA0756-0757 deletion mutant was slightly more sensitive to
ciprofloxacin.
Taken together with the biofilm formation, MBC-P and MIC
data showing that DPA0756-0757, DPA2070 and DPA5033
generally had no defect in these assays, we concluded that these
deletion mutants were specifically deficient in antibiotic resistance
only when growing in biofilms.

Cloned PA0756-0757, PA2070 and PA5033 genes
increase the resistance of planktonic cells
In order to assess whether PA0756-0757, PA2070 and PA5033
can promote antibiotic resistance when overexpressed from a
vector in planktonic cells, intact PA0756-0757, PA2070 and
PA5033 genes from PA14 were individually cloned into a boardhost-range vector, pJB866, which carries the m-toluic acidcontrolled Pm promoter [16]. Compared with planktonic PA14
cells carrying the vector only, the cells containing the cloned genes
in pJB866 (pre-induced with m-toluic acid) showed decreased
susceptibility to tobramycin (2-fold MIC change from 4 to 8 mg/
ml, gentamicin (4 to 8-fold MIC change from 2 to 8 or 16 mg/ml)
and ciprofloxacin (2 to 4-fold MIC change from 0.25 to 0.5 or
1.0 mg/ml) (Table 5). These results suggest that PA0756-0757,
PA2070 and PA5033 may act independently as antibiotic
resistance genes. Taken together with the previously published
data showing that ndvB, PA1875-1877 and tssC1 are also able to
increase planktonic antibiotic resistance when expressed from a
vector in planktonic cells, this suggests that a mechanism of
biofilm-specific expression likely contributes to biofilm-specific
antibiotic resistance.

ndvB and PA0756-0757 represent different biofilmspecific antibiotic resistance mechanisms
Previously, we showed that ndvB is important for biofilm-specific
resistance to tobramycin through a mechanism involving sequestration of the antibiotic by ndvB-derived glucans [10]. To test
whether ndvB and PA0756-0757 function in the same pathway, we
constructed a deletion mutant combining the ndvB mutation and
the PA0756-0757 deletions. The antibiotic resistance phenotype of
the resulting mutant, DndvB/DPA0756-0757, was determined in
MBC-P and MBC-B assays (Table 3). In comparison to each single
deletion mutant, the double mutant exhibited an increased
sensitivity to tobramycin and gentamicin in the MBC-B assay,
suggesting that the ndvB-mediated mechanism of antibiotic
resistance is separate from the mechanism represented by
PA0756-0757. This result is consistent with previous experiments
with a DndvB/DPA1874-1877 double mutant [11] and supports
the theory that there are multiple mechanisms of resistance acting
within a biofilm.

Biofilm-specific antibiotic resistance genes contribute to
PA14 persistence in a C. elegans slow-killing assay
C. elegans responds to pathogenic microbes including the lethal
infections by P. aeruginosa and thus has been used as an in vivo
pathogenesis model. P. aeruginosa can kill C. elegans in a slow-killing
assay where death after the ingestion of the bacteria occurs within
three days [22]. In contrast to the fast-killing assay that is
dependent on the delivery of toxins to the host [23], the slowkilling assay is based on the ability of P. aeruginosa to accumulate in
the intestine of the worm [22,24,25]. The exact mechanism of
pathogenesis in the slow-killing assay is unclear but it is clearly an
active process because heat-killed P. aeruginosa are not pathogenic
in this model [22]. Since the slow-killing assay is described as an
infectious process [26], it is likely that the initial steps of the
infection entail the establishment of a biofilm and subsequent
resistance to the host immune system. Thus, the slow-killing C.
elegans assay measures the ability of P. aeruginosa to persist in the
host, followed by active killing of the host. In order to address
whether genes that are important for biofilm-specific antibiotic
resistance in vitro are also important in a pathogenicity model that
depends on P. aeruginosa persistence, we tested whether DPA07560757, DPA2070 and DPA5033 mutants were defective in the slow-

PA0756-0757, PA2070 and PA5033 display a biofilmspecific expression pattern
The previously-characterized ndvB, PA1875-1877 and tssC1
genes each exhibit a higher level of gene expression in biofilm cells,
compared to planktonic cells [10–12]. In order to determine if
PA0756-0757, PA2070 and PA5033 were similarly regulated, we
performed quantitative mRNA-based real-time PCR experiments
comparing the expression of these genes in planktonic- and
biofilm-grown cells (Figure 2). All three loci exhibited a higher
level of gene expression in biofilm cells, suggesting that these genes
are important for biofilm resistance, but not planktonic resistance,
because their expression is limited to biofilms.
PLOS ONE | www.plosone.org
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Figure 1. Inactivation of PA0756-0757, PA2070 or PA5033 does not affect biofilm formation. A. Air-liquid interface assay of biofilm
formation of P. aeruginosa PA14 wild type and its deletion mutants, DPA0765-0757, DPA2070 and DPA5033. The images of biofilms at 200 X
magnification were taken by phase-contrast microscopy after 24 h of growth at 37uC in M63-arginine medium. B. Quantification of biofilm formation
by measurement of the biofilm-associated crystal violet (OD550). The data shown are the mean 6 standard deviation from two separate experiments
(each with quadruplicate samples) using the microtitre plate biofilm assay and display no significant difference (p.0.05) among the four groups as
determined by one-way ANOVA.
doi:10.1371/journal.pone.0061625.g001

killing C. elegans assay. The controls for the experiments were P.
aeruginosa PA14 wild type as the positive control (0% survival at
72 hours) and E. coli OP50 as the negative control (100% survival
at 72 hours). The three biofilm resistance gene deletion mutants
were all attenuated in the slow-killing assay, with survival values
PLOS ONE | www.plosone.org

ranging from 31.8% (DPA5033) to 55% (DPA2070) (Figure 3).
Similar results were obtained when DndvB, DPA1874-1877 and
DtssC1 were used in slow-killing C. elegans assay (Figure S1). An
sadC mutant of P. aeruginosa defective in biofilm formation [27] was
also included for comparison since biofilm formation-deficient
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Table 3. Minimal bactericidal concentrations of antibiotics for
PA14 deletion mutants tested with planktonic cells (MBC-P)
and biofilm cells (MBC-B) (mg/ml)a.

Table 4. Antibiotic susceptibility of PA14 deletion mutants
assayed in LB broth.

Strain
Tobramycin

Gentamicin

Ciprofloxacin

MBC-P

MBC-B

MBC-P

MBC-B

MBC-P

MBC-B

PA14

32

200

64

200–400

4

80

DndvB

32

50

64

50–100

4

DPA2070

32

50

64

100

DPA5033

16

100

32

100–200

Strain

Minimal inhibitory concentration (MIC; mg/ml)
Tobramycin

Gentamicin

Ciprofloxacin

PA14

2

2

0.5

DndvB

2

2

0.5

40

DPA2070

2

1–2

0.5

4

80

DPA5033

2

2

0.5

2–4

80

DPA0756-0757

2

2

0.25

DndvB DPA0756-0757 2

2

0.25

DPA0756-0757 16

25–50

64

100

2

80

DndvB
16–32
DPA0756-0757

12.5–25

64

25–50

2

40
doi:10.1371/journal.pone.0061625.t004

tricarboxylate uptake [27]. However, it is not clear if this occurs in
biofilms. Two genes immediately downstream of PA0756-0757
encode yet-uncharacterized hypothetical products. To date, several
two-component regulatory systems have been implicated in biofilm
formation, often as part of complex regulatory networks that govern
the production of exopolysaccharides or the expression of surface
appendages (reviewed in [28]), but this is the first two-component
regulatory system to be identified to be important for biofilmspecific antibiotic resistance. The signal, or signals, that the PA0757
sensor histidine kinase responds to in biofilms has not been
identified, although tricarboxylates are candidates. We predict that
the downstream targets of the PA0756 response regulator will
possibly be involved in biofilm-specific antibiotic resistance.
PA2070 and PA5033 are both predicted to encode hypothetical
proteins of unknown function [21]. PA5033 has a type I export
signal and the TIGRFAM predicts that PA2070 is a part of the
TonB-dependent heme/hemoglobin receptor family. In fact,
functional data has implicated PA2070 in a cell-surface signaling
pathway that involves the extracytoplasmic function sigma factor
PA2050 with possible function in metal uptake [29]. The genes
upstream and downstream of PA2070 encode, respectively,
elongation factor G (FusA2; PA2071) and a carbamoyl transferase
(PA2069), while the gene products from upstream and downstream of PA5033 are, respectively, a putative transcriptional
regulator (PA5032) and an uroporphyrinogen decarboxylase
(HemE). None of these gene products are known to be involved
in biofilms. Therefore, given their predicted locations/function,
further investigation of the function of PA2070 and PA5033
proteins in biofilm-specific antibiotic resistance will likely provide
insights on additional novel mechanisms of resistance.

a
the values represent the mode of at least 6 biological replicates.
doi:10.1371/journal.pone.0061625.t003

mutants are attenuated in the C. elegans slow-killing assay, likely
due to the fact that they do not accumulate in the worm intestine
(Figure S1) [24]. These results suggest that there is a correlation
between biofilm sensitivity to antibiotics in vitro and an inability to
kill C. elegans in vivo. More C. elegans survived the exposure to the
DsadC mutant (61.4%), suggesting that this mutant was cleared by
the host more efficiently.

Discussion
In this study, we have described the identification of three novel
biofilm-specific antibiotic resistance genes in P. aeruginosa. Together
with three previously characterized biofilm-specific antibiotic
resistance genes, a total of six genes were identified in a genetic
screen [10–12]. Each one of these genes is more highly expressed in
biofilms, compared to planktonic cultures, and protects biofilm cells
from antibiotics, likely through separate mechanisms. We also
present evidence to suggest that in vivo, each gene is required to
prevent the elimination of P. aeruginosa during an infection of C. elegans
and therefore are important for persistence and pathogenesis in vivo.
PA0756 and PA0757 are predicted to encode a two-component
regulatory system [21]. These types of systems relay information
from outside of the cell into the cells and the result of this pathway is
the response of the cells to a specific signal. In planktonic cultures,
PA0756-0757 represses the expression of OpdH, a porin that is
encoded by the upstream gene (PA0755) of PA0756-0757 operon
transcribed in the opposite direction. OpdH is involved in

Figure 2. qPCR analysis of the expression of PA0756, PA2070 and PA5033 in planktonic and biofilm cells. For each condition, three
biological replicate samples were tested in triplicate qPCRs.
doi:10.1371/journal.pone.0061625.g002
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Table 5. Antibiotic susceptibility of PA14 deletion mutants containing pJB866-based plasmids and assayed in LB.

Minimal inhibitory concentration (MIC; mg/ml)

Strain

m-toluic acid induction (2 mM)

Tobramycin

Gentamicin

Ciprofloxacin

PA14 pJB866

2

2

2

0.25

+

4

2

0.25

2

4

4

1

+

8

16

1

2

4

4

0.25

+

8

16

1

2

2

4

0.25

+

8

16

1

PA14 pJB866-PA2070

PA14 pJB866-PA5033

PA14 pJB866-PA0756-0757

doi:10.1371/journal.pone.0061625.t005

antibiotics only when the bacteria are growing in a biofilm (Table 3)
[10–12]. Despite the modest decreases in antibiotic resistance of
each single deletion mutant in vitro, our results revealed that the 6
mutants tested are all deficient in the in vivo C. elegans slow killing
assay. Depending on the exact mechanism of antibiotic resistance
represented by each gene, the in vitro phenotype of antibiotic
sensitivity could equate to in vivo sensitivity to host immune factors.
A key signaling pathway in the C. elegans innate immune response is
regulated by a conserved p38 MAP kinase [30,31]. This pathway
results in the expression of uncharacterized immune effectors that
likely possess antimicrobial activities [31]. The mechanisms of
resistance represented by ndvB, PA1874-1877, tssC1, PA0756-0757,
PA2070 or PA5033 may be important for protection against
antibiotics as well as the antimicrobial compounds produced by the
C. elegans innate immune system.

The combination of mutations in ndvB and PA0756-0757
operon resulted in a mutant that was more sensitive to
antibiotics compared to a single mutation in either genetic
locus suggests that they represent separate resistance mechanisms. ndvB and PA1875-1877 also represent different resistance
mechanisms [11]. Our current work suggests that there are
additional mechanisms of resistance in biofilms, represented by
PA0756-0757, PA2070 and PA5033, that have yet to be
characterized. Taken together with the fact that other mechanisms, such as the induction of a lipid modification system [9],
have been identified through different types of approaches, it is
clear that biofilm-specific antibiotic resistance encompasses
multiple mechanisms of resistance.
Loss of either ndvB, PA1874-1877, tssC1, PA0756-0757, PA2070
or PA5033 results in a deletion mutant that is more sensitive to

Figure 3. DPA0756-0757, DPA2070 and DPA5033 are attenuated in a C. elegans slow-killing model. Slow-killing conditions were used for
each strain and death of C. elegans was measured every 24 h for a total of 72 h. Exposure to bacterial lawn represents when L4 or young adult
hermaphrodite C. elegans were added to pathogenic plates. Values represent the results from at least three biological replicates. Error bars represent
standard deviation, and lack of error bars means a standard deviation of zero.
doi:10.1371/journal.pone.0061625.g003
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The fast-killing C. elegans assay is a toxin-based mode of killing
where the worms die within one day [22–24]. As such, it
represents more of an acute type infection. In contrast, the slowkilling assay allows for the study of the host-pathogen interactions
because microbes including P. aeruginosa can establish an infection
within the intestine of the worm [25]. This infection is
characterized by the accumulation of bacteria and a matrix in
the intestine [25] and likely relies on the establishment of a biofilm
within the intestine. The fact that the DsadC, a mutant that is
impaired in biofilm formation, was more defective in the slowkilling assay compared to the biofilm antibiotic resistance gene
deletion mutants, is consistent with the concept that biofilm
formation is also an important aspect of P. aeruginosa persistence
and pathogenesis in the C. elegans slow-killing model.

conditions were used for each strain and death of C. elegans was
measured every 24 h for a total of 72 h. Exposure to bacterial
lawn represents when L4 or young adult hermaphrodite C. elegans
were added to pathogenic plates. Values represent the results from
at least three biological replicates. Error bars represent standard
deviation, and lack of error bars means a standard deviation of
zero.
(TIFF)
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